SUMMARY HIV diagnostics have played a central role in the remarkable progress in
identifying, staging, initiating, and monitoring infected individuals on life-saving antiretroviral …

Affordable, sensitive, and scalable technologies are needed for monitoring antiretroviral
treatment (ART) success with the goal of eradicating HIV-1 infection. This review discusses …

Increased provision of antiretroviral therapy in sub-Saharan Africa has led to a growing
number of patients with therapy failure and acquired drug-resistant HIV, driving the demand …

Objective: We developed the Healthy Families-PrEP intervention to support HIV-prevention
during periconception and pregnancy. We evaluated preexposure prophylaxis (PrEP) use …

Objectives To analyze the patterns and risk factors of HIV drug resistance mutations among
patients failing second-line treatment and to describe early treatment responses to …

Objectives In low–middle-income countries, increasing levels of HIV drug resistance
(HIVDR) on second-line protease inhibitor (PI)-based regimens are a cause for concern …

Background. Second-line antiretroviral therapy (ART) based on ritonavir-boosted protease
inhibitors (bPIs) represents the only available option after first-line failure for the majority of …

There is evidence of increasing levels of pretreatment HIV drug resistance (PDR) in
Southern Africa. We used data from two large population-based HIV surveillance studies to …

Objectives: The integrase strand inhibitor dolutegravir (DTG) combined with tenofovir and
lamivudine (TLD) is a single tablet regimen recommended for 1st, 2nd and 3rd-line public …

Global scale-up of antiretroviral treatment has dramatically changed the prospects of
HIV/AIDS disease, rendering life-long chronic care and treatment a reality for millions of HIV …